Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Primary chemotherapy with doxorubicin and paclitaxel in patients with early breast cancer: final results of a multicenter phase II study.
Schmid P, Krocker J, Morack G, Heilmann V, Blohmer JU, Michniewicz K, Köhler G, Schaller-Kranz T, Possinger K, Elling D. Schmid P, et al. Among authors: krocker j. J Cancer Res Clin Oncol. 2004 Nov;130(11):657-63. doi: 10.1007/s00432-004-0599-y. Epub 2004 Aug 20. J Cancer Res Clin Oncol. 2004. PMID: 15322862 Clinical Trial.
Primary chemotherapy with gemcitabine as prolonged infusion, non-pegylated liposomal doxorubicin and docetaxel in patients with early breast cancer: final results of a phase II trial.
Schmid P, Krocker J, Jehn C, Michniewicz K, Lehenbauer-Dehm S, Eggemann H, Heilmann V, Kümmel S, Schulz CO, Dieing A, Wischnewsky MB, Hauptmann S, Elling D, Possinger K, Flath B. Schmid P, et al. Among authors: krocker j. Ann Oncol. 2005 Oct;16(10):1624-31. doi: 10.1093/annonc/mdi321. Epub 2005 Jul 19. Ann Oncol. 2005. PMID: 16030028 Free article. Clinical Trial.
FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients.
Fasching PA, Jud SM, Hauschild M, Kümmel S, Schütte M, Warm M, Hanf V, Grab D, Krocker J, Stickeler E, Kreienberg R, Müller T, Kühn T, Wolf C, Kahlert S, Paepke S, Berghorn M, Muth M, Baier M, Wackwitz B, Schulz-Wendtland R, Beckmann MW, Lux MP. Fasching PA, et al. Among authors: krocker j. BMC Cancer. 2014 Feb 5;14:66. doi: 10.1186/1471-2407-14-66. BMC Cancer. 2014. PMID: 24499441 Free PMC article. Clinical Trial.
Adjuvant treatment of breast cancer patients with 1-3 positive lymph nodes: vinorelbine plus epirubicin; vinorelbine plus epirubicin sequential followed up by paclitaxel; epirubicin plus cyclophosphamide; epirubicin plus cyclophosphamide sequential followed up by paclitaxel. A phase II study.
Elling D, Eggemann H, Kümmel S, Breitbach P, Kohls A, Morack G, Schlosser H, Krocker J. Elling D, et al. Among authors: krocker j. Breast. 2003 Jun;12(3):208-11. doi: 10.1016/s0960-9776(03)00010-9. Breast. 2003. PMID: 14659328 Clinical Trial.
Dose-dense adjuvant chemotherapy for node-positive breast cancer in women 60 years and older: feasibility and tolerability in a subset of patients in a randomized trial.
Kümmel S, Krocker J, Kohls A, Breitbach GP, Morack G, Budner M, Blohmer JU, Lichtenegger W, Elling D. Kümmel S, et al. Among authors: krocker j. Crit Rev Oncol Hematol. 2006 May;58(2):166-75. doi: 10.1016/j.critrevonc.2005.08.009. Epub 2006 Jan 18. Crit Rev Oncol Hematol. 2006. PMID: 16387512
27 results